Action FNCH FINCH THERAPEUTICS GROUP, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Finch Therapeutics Group, Inc.

Actions

FNCH

US31773D2009

Temps Différé Nasdaq
Autres places de cotation
 17:40:15 29/04/2024 		Varia. 5j. Varia. 1 janv.
2,261 USD -2,56% Graphique intraday de Finch Therapeutics Group, Inc. -2,13% -37,38%
25/03 Finch Therapeutics Group, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
12/03 Les plus mauvais élèves du prémarché MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Top Premarket Decliners
North American Morning Briefing : Stocks Seen -2-
Finch Therapeutics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
North American Morning Briefing : Stock Futures -2-
Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Value Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Value Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Index
Top Premarket Decliners
Finch Therapeutics Group Slumps Almost 15% in Premarket Tuesday
FINCH THERAPEUTICS GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Finch Therapeutics Group to Implement 1-for-30 Reverse Stock Split
Finch Announces Reverse Stock Split of Common Stock
Finch Announces Reverse Stock Split of Common Stock
FINCH THERAPEUTICS GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
FINCH THERAPEUTICS GROUP, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FNCH
  4. Actualités Finch Therapeutics Group, Inc.
  5. Autres langues